Articles From: Harsco Secures Its Second $100 Million+ Railway Maintenance Equipment Contract in Switzerland to Harwood Feffer LLP Announces Investigation of AcelRx Pharmaceuticals, Inc.


CAMP HILL, Pa., July 1, 2014 (GLOBE NEWSWIRE) -- Diversified global industrial company Harsco Corporation (NYSE:HSC) announced today its second major railway track and infrastructure maintenance equipment award from SBB, the federal railway system of Switzerland.
Sign-up for Harsco Secures Its Second $100 Million+ Railway Maintenance Equipment Contract in Switzerland investment picks
CAMP HILL, Pa., Sept.
Sign-up for Harsco's Patterson-Kelley Division Launches Innovative Touchscreen Boiler Control Platform investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0961581001&sourceType=1 http://www.ccnmatthews.com/logos/20091123-Hartco_200.jpg MONTREAL, QUEBEC --
Sign-up for Hartco Announces 2014 Second Quarter Results investment picks
2014/8/19
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0963653001&sourceType=1 http://media3.marketwire.com/docs/hartelogoLG.jpg TORONTO, ONTARIO --
Sign-up for Harte Gold Announces Closing of Private Placement investment picks
2014/7/31
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0960529001&sourceType=1 http://media3.marketwire.com/docs/hartelogoLG.jpg TORONTO, ONTARIO --
Sign-up for Harte Gold Announces Final Closing of Private Placement Provides Exploration Update investment picks
2014/9/29
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0970054001&sourceType=1 http://media3.marketwire.com/docs/hartelogoLG.jpg TORONTO, ONTARIO --
Sign-up for Harte Gold Reports More High Grade Results at Wolf Zone, 17.8g/t Gold Over 3.1 Meters Extends Wolf Zone & Identifies Parallel Mineralized Sulphide Zones investment picks
http://media.marketwire.com/attachments/201310/197741_HHlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1140670&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for Harte Hanks Announces $20 Million Stock Repurchase Program investment picks
http://media.marketwire.com/attachments/201310/197741_HHlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1133458&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for Harte Hanks Announces 2nd Quarter 2014 Financial Results Conference Call investment picks
http://media.marketwire.com/attachments/201310/197741_HHlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1134918&ProfileId=051205&sourceType=1 CHICAGO, IL --
Sign-up for Harte Hanks Declares Regular Quarterly Dividend investment picks
http://media.marketwire.com/attachments/201310/197741_HHlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1134457&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for Harte Hanks Reports Second Quarter Results investment picks
The Hartford Steam Boiler Inspection and Insurance Company (HSB), a leading engineering and technical risk insurer, and Guidewire Software, Inc. (NYSE:GWRE), a provider of software products to Property/Casualty (P/C) insurers, today announced that HSB has successfully deployed Guidewire ClaimCenter® as its new platform for claims management.
Sign-up for Hartford Steam Boiler Deploys Guidewire System for Claims Management investment picks
Harvard Apparatus Regenerative Technology, Inc. (NASDAQ:HART), or HART, a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the HART-Trachea, which is intended to replace or repair a trachea that has been severely damaged by either trachea cancer or physical trauma.
Sign-up for Harvard Apparatus Regenerative Technology Obtains Orphan Drug Designation from U.S. Food and Drug Administration for HART-Trachea investment picks
Harvard Apparatus Regenerative Technology, Inc. (Nasdaq:HART), or HART, a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, reports unaudited financial results for the three and six months ended June 30, 2014.
Sign-up for Harvard Apparatus Regenerative Technology Reports Operating Results for Second Quarter Ended June 30, 2014 investment picks
Harvard Apparatus Regenerative Technology, Inc. (NASDAQ:HART), a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, will announce results of its second quarter ended June 30, 2014 before market trading hours on Friday, August 8, 2014.
Sign-up for Harvard Apparatus Regenerative Technology Schedules Release of Second Quarter 2014 Financial Results and Investor Teleconference for August 8th investment picks
Expected to Add $7.5 Million to $8.5 Million in Revenue in 2015 HOLLISTON, Mass., Oct.
Sign-up for Harvard Bioscience Acquires Multi Channel Systems MCS GmbH and Triangle BioSystems, Inc. investment picks
Revenues Increased Three Percent in the Second Quarter -Conference Call To Be Held at 11:00 AM ET Today- HOLLISTON, Mass., July 31, 2014 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO) , a global developer, manufacturer and marketer of a broad range of solutions to advance life science, today reported financial highlights for the three and six months ended June 30, 2014.
Sign-up for Harvard Bioscience Reports Second Quarter 2014 Results investment picks
HOLLISTON, Mass., July 16, 2014 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO) , a global developer, manufacturer, and marketer of a broad range of equipment, instruments and solutions to advance life science, will announce results for its second quarter before market trading hours on Thursday, July 31, 2014.
Sign-up for Harvard Bioscience Schedules Second Quarter 2014 Conference Call for July 31, 2014 at 11:00 AM ET investment picks
2014/9/17
http://media.marketwire.com/attachments/201401/215925_11Varonis_Horizontal_HEX_Whitespace.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1145200&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for Harvard Business Review Highlights 'The Danger From Within' as Varonis Continues to Protect Companies From Internal Threats investment picks
Harvest Capital Credit Corporation (“Harvest Capital” or the “Company”) (NASDAQ:HCAP) announced that its Board of Directors declared distributions of $0.1125 per share for the months of July, August and September.
Sign-up for Harvest Capital Credit Corporation Announces June 30, 2014 Financial Results and Declares Distributions for July, August and September investment picks
Harvest Capital Credit Corporation (NASDAQ: HCAP ), announced today that it will report financial results for the fiscal quarter ended June 30, 2014 before market open on Wednesday, August 13, 2014.
Sign-up for Harvest Capital Credit Corporation to Report Second Quarter 2014 Results on August 13, 2014 investment picks
2007/12/13
Lock in your 2007 gains while keeping taxes low.
Sign-up for Harvest Gains in Your Portfolio investment picks
HOUSTON , Aug.
Sign-up for Harvest Natural Resources Announces 2014 Second Quarter Results investment picks
HOUSTON , Sept.
Sign-up for Harvest Natural Resources Announces At-The-Market Equity Financing Program investment picks
HOUSTON , July 21, 2014 /PRNewswire/ -- Harvest Natural Resources, Inc .
Sign-up for Harvest Natural Resources Announces Declaration Of Commerciality And Exclusive Exploitation Authorization For The Dussafu Block Offshore Gabon investment picks
2014/7/22
Harvey Nash Inc. , an IT recruitment, IT outsourcing/offshoring and executive search firm, today announced that Jefferies LLC, a global investment banking firm, selected Harvey Nash to deliver infrastructure end-user support to the company’s global operations in multiple locations across North America, Europe and Asia.
Sign-up for Harvey Nash Inc. Chosen by Investment Banking Firm Jefferies to Provide Global Infrastructure End-User Support investment picks
NEW YORK , Sept.
Sign-up for Harwood Feffer LLP Announces Conversant, Inc. Investigation investment picks
NEW YORK , Oct.
Sign-up for Harwood Feffer LLP Announces Investigation of AcelRx Pharmaceuticals, Inc. investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Harsco Secures Its Second $100 Million+ Railway Maintenance Equipment Contract in Switzerland to Harwood Feffer LLP Announces Investigation of AcelRx Pharmaceuticals, Inc.
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices